To identify if ATRA signaling was functional in MPNST cell lines treated with ATRA, we analyzed expression of bona fide CRABP2 targets such as CRABP2 itself, CYP26A1 and RARB by qRT-PCR. This evidence concerns the gene CYP26A1 and malignant peripheral nerve sheath tumor.